by European Public Health Alliance | Dec 14, 2020 | Antimicrobial Resistance | Analysis & Opinion
By Zoltan Massay-Kosubek, Policy Manager, EPHA, Federico Pisani, Policy Assistant, EPHAThe MEP Interest Group on AMR organised a forward-looking discussion on the current state and prospects for the future of the antibiotic innovation pipeline as part of their series...
by European Public Health Alliance | Dec 14, 2020 | Antimicrobial Resistance | Analysis & Opinion
By Zoltan Massay-Kosubek, Policy Manager, EPHA and Federico Pisani, Policy Assistant, EPHA The COVID-19 pandemic has shed light on the essential role that health plays in all aspects of our societies. Leading to new and old priorities being studied and tackled. Among...
by European Public Health Alliance | Dec 14, 2020 | Antimicrobial Resistance | Analysis & Opinion
Guest article Jean-Yves Stenuick, Pharmaceuticals Policy & Projects Officer, Health Care Without Harm (HCWH) Europe The MEP Interest Group on AMR organised an online discussion on the environmental aspects of antimicrobial resistance on 13 November 2020 as part...
by Ann Marie Borg | Mar 3, 2020 | Antimicrobial Resistance | Analysis & Opinion, MEPs fight AMR
A packed room of key actors, including Health Commissioner Stella Kyriakides, committed to tackling Antimicrobial Resistance (AMR) from a One Health approach, joined MEPs for the launch of the MEP interest group on AMR which took place on 19 February 2020 in the...
by Ann Marie Borg | Feb 6, 2020 | Antimicrobial Resistance | Analysis & Opinion
“Never has the threat of antimicrobial resistance been more immediate and the need for solutions more urgent”, Dr Tedros Adhanom Ghebreyesus, Director-General, World Health Organization. The recent Coronavirus outbreak has reminded us that health threats do not stop...
by Ann Marie Borg | Nov 20, 2019 | Antimicrobial Resistance | Analysis & Opinion
In April 2011, Mohammed, a software developer based in the United Kingdom and Egypt, developed acute myeloid leukaemia, and while receiving chemotherapy, developed an E.Coli infection. Thanks to a specific combination of high-dose antibiotics, doctors were able to...
